
Mirella Salvatore MD FIDSA
International Health, Travel & Tropical
Associate Professor of Medicine and Associate Professor of Population Health Sciences Weill Cornell Medicine
Join to View Full Profile
1300 York AveRm A479New York, NY 10065
Phone+1 212-746-6913
Fax+1 212-746-8675
Dr. Salvatore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mirella Salvatore is an Associate Professor of Medicine at the Sanford I. Weill Medical College of Cornell University and an Attending Physician at the New York-Presbyterian Hospital Cornell campus. She obtained her M.D. degree from the Catholic University in Rome, Italy and completed her Internal Medicine Residency and Fellowship in Infectious Diseases at the Mount Sinai School of Medicine in New York City. At Mount Sinai she also completed a postdoctoral fellowship training studying influenza virus in the laboratory of Prof. Adolfo Garcia-Sastre.
As a physician scientist, Dr. Salvatore has focused her research on the development of novel platforms for influenza vaccines and more recently, on Covid-19. She is also leading studies of influenza virus pathogenesis and therapy in the immunocompromised human host. She is a member of the International Society for Influenza and other Respiratory Virus Diseases (ISIRV), International Society for Travel Medicine (ISTM) and she is a fellow of the Infectious Diseases Society of America (IDSA) and Vice President of the Infectious Disease Society of New York (IDSNY). She is also a former member of the IDSA Research Committee and of ISTM Research and Awards Committee. Dr. Salvatore has served on NIH study sections, and is a reviewer for many scientific journals.
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2003 - 2005
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Infectious Disease, 2001 - 2003
- University of Cattolica del Sacro CuoreClass of 1986
Certifications & Licensure
- NY State Medical License 2004 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- Cornell UniversityClinical and Translational Investigation
- ISTMCertificate in Travel Health, International Society of Travel Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza Start of enrollment: 2022 Apr 22
Roles: Contact, Principal Investigator
- Respiratory Virus Hospitalization Study (FLU 003 Plus)
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 7 citationsEmergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections.Mohammed Nooruzzaman, Katherine E E Johnson, Ruchi Rani, Eli J Finkelsztein, Leonardo C Caserta
Nature Communications. 2024-09-18 - 2 citationsEmergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections.Mohammed Nooruzzaman, Katherine E E Johnson, Ruchi Rani, Eli J Finkelsztein, Leonardo C Caserta
Medrxiv. 2024-06-18 - 3 citationsEarly immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals.Jacqueline M Leung, Michelle J Wu, Pouya Kheradpour, Chen Chen, Katherine A Drake
Frontiers in Immunology. 2024-01-01
Press Mentions
- Antiviral-Resistant Variants of SARS-CoV-2 Can Emerge in Immunocompromised PeopleSeptember 18th, 2024
- Antiviral-Resistant Variants of SARS-CoV-2 Can Emerge in Immunocompromised PeopleSeptember 18th, 2024
- COVID Antivirals Fight Omicron Better Than Monoclonal AntibodiesMay 5th, 2022
- Join now to see all
Grant Support
- The effects of immunosuppression on SARS-CoV-2 persistence, virus genetic diversity and clinical outcomes of COVID-19WEILL MEDICAL COLL OF CORNELL UNIV2024–2026
Committees
- Vice President, Infectious Disease Society of New York 2024 - Present
- Member, IDSA Continuing Education Subcommittee 2024 - Present
- Member, IDSA Research Committee 2019 - 2023
- Member, ISTM Research and Award Commitee 2017 - 2021
Professional Memberships
- Infectious Diseases Society of America (IDSA)Fellow
- International Society of travel medicine (ISTM)Member
- International Society for Influenza and other Respiratory Virus diseases (ISIRV)Member
Other Languages
- Italian
External Links
- Publications NCBIhttp://ncbi.nlm.nih.gov/myncbi/mirella.salvatore.1/bibliography/public/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: